Match tier
Listed
Presence
Current · Arkansas
Last published
2020
Sources
OpenAlex · ORCID
Refreshed
2026-10-03
A
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Aaron Owen's research interests include health sciences and medical education. He has contributed to the field through his publications, with his most recent work appearing in 2020. Owen's academic background at the University of Arkansas for Medical Sciences informs his contributions to health sciences research and education.
Metrics
- h-index: 6
- Publications: 7
- Citations: 298
Selected Publications
-
Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model (2020)
-
Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene. (2017)
-
Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients (2017)
-
Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients (2016)
Collaboration Network
Top Collaborators
Valentina K. Todorova
University of Arkansas Medical Center
4 shared publications
In database
- Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model
- Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Issam Makhoul
University of Arkansas for Medical Sciences
4 shared publications
In database
- Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model
- Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Jeanne Y. Wei
University of Arkansas for Medical Sciences
4 shared publications
In database
- Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model
- Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Eric R. Siegel
University of Arkansas for Medical Sciences
3 shared publications
In database
- Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Annjanette Stone
Central Arkansas Veterans Healthcare System (US)
2 shared publications
- Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Weleetka Carter
Central Arkansas Veterans Healthcare System (US)
2 shared publications
- Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
V. Suzanne Klimberg
University of Arkansas for Medical Sciences (US)
2 shared publications
- Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Asangi R. Kumarapeli
University of Arkansas for Medical Sciences
2 shared publications
In database
- Dantrolene Attenuates Cardiotoxicity of Doxorubicin Without Reducing its Antitumor Efficacy in a Breast Cancer Model
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Marjorie L. Beggs
Arkana Laboratories (US)
1 shared publication
- Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Ishwori Dhakal
University of Arkansas for Medical Sciences (US)
1 shared publication
- Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
V. Suzanne Klimberg
University of Arkansas for Medical Sciences (US)
1 shared publication
- Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Yihong Jiang-Cao Kaufmann
University of Arkansas for Medical Sciences (US)
1 shared publication
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Julia H. Aronson
University of Arkansas for Medical Sciences (US)
1 shared publication
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Sue A. Theus
University of Arkansas for Medical Sciences (US)
1 shared publication
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Suzanne Klimberg
University of Arkansas for Medical Sciences (US)
1 shared publication
- Reducing doxorubicin cardiotoxicity in rats with mammary tumors by dantrolene.
Similar Researchers
Based on overlapping research topics
James L. Barrentine
University of Arkansas at Fayetteville
Health Sciences Research and Education
Medical Education
Aaroop Haridas
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Medical Education
Thomas Monson
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Medical Education
Nancy Sessoms
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Medical Education
Raga Deepak Reddy Palagiri
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Medical Education
Kiley Jones
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Medical Education